Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Danda P. Chapagai
Observed names:
Chapagai, Danda Pani,
Danda Chapagai
Institution:
University of South Carolina
Observed institutions:
East Tennessee State University,
Harvard University,
University of South Carolina,
Massachusetts General Hospital,
Florida Atlantic University
ORCID:
0000-0003-3317-0658
Observed ORCID:
0000-0003-3317-0658
OpenAlex ID:
A5003615712
Structural regulation of PLK1 activity: implications for cell cycle function and drug discovery
2025
·
Danda Chapagai
, Klaus Strebhardt
, et al.
·
Cancer Gene Therapy
·
24
PDF
Nonpeptidic, Polo-Box Domain-Targeted Inhibitors of PLK1 Block Kinase Activity, Induce Its Degradation and Target-Resistant Cells
2021
·
Danda Chapagai
, Gurusankar Ramamoorthy
, et al.
·
Journal of Medicinal Chemistry
·
21
PDF
Hormone Signaling: Current Perspectives on the Roles of Salicylic Acid and Its Derivatives in Plants
2015
·
Dhirendra Kumar
, Imdadul Haq
, et al.
·
Springer eBooks
·
20
Biotic and Abiotic Stress Signaling Mediated by Salicylic Acid
2015
·
Dhirendra Kumar
, Danda Chapagai
, et al.
·
Springer eBooks
·
17
Structural Basis for Variations in Polo-like Kinase 1 Conformation and Intracellular Stability Induced by ATP-Competitive and Novel Noncompetitive Abbapolin Inhibitors
2023
·
Danda Chapagai
, George Merhej
, et al.
·
ACS Chemical Biology
·
16
PDF
Structure-activity and mechanistic studies of non-peptidic inhibitors of the PLK1 polo box domain identified through REPLACE
2021
·
Sandra N. Craig
, Merissa Baxter
, et al.
·
European Journal of Medicinal Chemistry
·
14
Peptidomimetic Polo‐Box‐Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor
2020
·
Merissa Baxter
, Danda Chapagai
, et al.
·
ChemMedChem
·
14
Biochemical Characterization of SBIP-470 and its role in SA-mediated Signaling in Plants
2014
·
Danda Chapagai
·
Digital Commons - East Tennessee State University (East Tennessee State University)
·
2
PDF
Abbapolin inhibitors of the PLK1 PBD as Prostate Cancer Therapeutics, in vivo activity and synergy with androgen therapy
2026
·
George Merhej
, Gurusankar Ramamoorthy
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Abstract 4993: Development of abbapolin inhibitors of the PLK1 PBD as potential therapeutics for prostate and other challenging cancers
2023
·
Jessy Stafford
, Danda Chapagai
, et al.
·
Cancer Research
Abstract 2572: A novel strategy for PLK1 kinase inhibition by allosterically targeting the Polo Box Domain
2022
·
Danda Chapagai
, Merissa Baxter
, et al.
·
Cancer Research
Abstract 1241: Converting high affinity peptides to non-peptidic inhibitors via REPLACE: Novel and new strategies in targeting PLK1 Polo Box Domain (PBD) for anti-cancer therapy
2021
·
Danda Chapagai
, Guru Ramamoorthy
, et al.
·
Cancer Research
Abstract 4712: Selective polo-like kinase 1 PBD inhibitor
2019
·
Danda P. Chapagai
, Merissa Baxter
, et al.
·
Cancer Research
Abstract 4712: Selective polo-like kinase 1 PBD inhibitor
2019
·
Danda P. Chapagai
, Merissa Baxter
, et al.
·
Experimental and Molecular Therapeutics
Abstract 3453: PAK6 localizes to centrosome and modulates centrosome homeostasis
2018
·
Houjun Jia
, Danda Chapagai
, et al.
·
Cancer Research
Show more works
View as search
Works count:
16
Citation count:
128
H-index:
7
I10-index:
7
Year
Topic
Type